Journal of Chromatography B 2013-06-01

Simultaneous determination of iloperidone and its two active metabolites in human plasma by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study

Mengmeng Jia, Jie Li, Xiaomeng He, Mingzhou Liu, Ying Zhou, Yue Fan, Weiyong Li

Index: J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 928 , 52-7, (2013)

Full Text: HTML

Abstract

• An LC/MS/MS method for simultaneous assay iloperidone and its metabolites in human plasma. • The method has an LLOQ of 10pg/mL for iloperidone and P88, and 50pg/mL for P95. • Liquid–liquid extraction is developed in sample preparation. • The validated method was successfully applied to a pharmacokinetic study in humans.

Related Compounds

  • Iloperidone

Related Articles:

A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.

2013-02-01

[J. Clin. Psychopharmacol. 33(1) , 3-10, (2013)]

Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial.

2013-02-01

[CNS Spectr. 18(1) , 43-54, (2013)]

Stable-isotope dilution LC-MS/MS assay for determination of iloperidone and its two major metabolites, P 88 and P 95, in human plasma: application to a bioequivalence study.

2013-03-01

[Bioanalysis 5(6) , 669-86, (2013)]

Role of α1 adrenergic antagonism in the mechanism of action of iloperidone: reducing extrapyramidal symptoms.

2013-12-01

[CNS Spectr. 18(6) , 285-8, (2013)]

Iloperidone: A new drug for the treatment of schizophrenia.

2011-02-15

[Am. J. Health Syst. Pharm. 68(4) , 301-8, (2011)]

More Articles...